Profound Historical Income Statement

PROF Stock  USD 7.35  0.08  1.08%   
Historical analysis of Profound Medical income statement accounts such as Research Development of 10.2 M, Total Operating Expenses of 21.3 M, Interest Income of 2 M or Discontinued Operations of 0.0 can show how well Profound Medical Corp performed in making a profits. Evaluating Profound Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Profound Medical's future profits or losses.
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Profound Medical Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Profound Medical Corp is a good buy for the upcoming year.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

About Profound Income Statement Analysis

Profound Medical Corp Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Profound Medical shareholders. The income statement also shows Profound investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Profound Medical Income Statement Chart

At this time, Profound Medical's Reconciled Depreciation is most likely to increase significantly in the upcoming years.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Profound Medical Corp. It is also known as Profound Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Profound Medical income statement and is an important metric when analyzing Profound Medical Corp profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.
Most accounts from Profound Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Profound Medical Corp current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
At this time, Profound Medical's Reconciled Depreciation is most likely to increase significantly in the upcoming years.
 2022 2023 2024 2025 (projected)
Interest Expense174K932.8K839.5K731.0K
Depreciation And Amortization2.1M1.1M1.3M1.3M

Profound Medical income statement Correlations

-0.150.840.84-0.8-0.850.83-0.820.82-0.830.62-0.83-0.20.82-0.38-0.870.520.710.97
-0.150.07-0.03-0.060.06-0.040.05-0.02-0.010.290.01-0.82-0.110.090.1-0.07-0.06-0.16
0.840.070.99-0.95-0.940.98-0.940.99-0.960.61-0.96-0.50.71-0.14-0.940.740.940.83
0.84-0.030.99-0.95-0.950.99-0.941.0-0.960.57-0.96-0.420.72-0.13-0.950.750.960.81
-0.8-0.06-0.95-0.950.96-0.960.97-0.950.98-0.610.980.52-0.760.190.97-0.73-0.89-0.79
-0.850.06-0.94-0.950.96-0.941.0-0.940.98-0.660.980.36-0.720.130.95-0.8-0.9-0.85
0.83-0.040.980.99-0.96-0.94-0.930.99-0.950.55-0.95-0.430.77-0.2-0.960.710.940.81
-0.820.05-0.94-0.940.971.0-0.93-0.940.98-0.650.980.37-0.70.10.95-0.82-0.91-0.82
0.82-0.020.991.0-0.95-0.940.99-0.94-0.950.55-0.95-0.430.71-0.12-0.940.750.970.8
-0.83-0.01-0.96-0.960.980.98-0.950.98-0.95-0.571.00.46-0.680.070.96-0.8-0.92-0.84
0.620.290.610.57-0.61-0.660.55-0.650.55-0.57-0.57-0.410.62-0.32-0.540.490.460.54
-0.830.01-0.96-0.960.980.98-0.950.98-0.951.0-0.570.44-0.680.080.96-0.8-0.92-0.85
-0.2-0.82-0.5-0.420.520.36-0.430.37-0.430.46-0.410.44-0.26-0.060.38-0.32-0.36-0.22
0.82-0.110.710.72-0.76-0.720.77-0.70.71-0.680.62-0.68-0.26-0.66-0.830.330.550.73
-0.380.09-0.14-0.130.190.13-0.20.1-0.120.07-0.320.08-0.06-0.660.250.410.09-0.24
-0.870.1-0.94-0.950.970.95-0.960.95-0.940.96-0.540.960.38-0.830.25-0.7-0.88-0.86
0.52-0.070.740.75-0.73-0.80.71-0.820.75-0.80.49-0.8-0.320.330.41-0.70.830.59
0.71-0.060.940.96-0.89-0.90.94-0.910.97-0.920.46-0.92-0.360.550.09-0.880.830.7
0.97-0.160.830.81-0.79-0.850.81-0.820.8-0.840.54-0.85-0.220.73-0.24-0.860.590.7
Click cells to compare fundamentals

Profound Medical Account Relationship Matchups

Profound Medical income statement Accounts

202020212022202320242025 (projected)
Depreciation And Amortization2.1M2.4M2.1M1.1M1.3M1.3M
Interest Expense543K303K174K932.8K839.5K731.0K
Selling General Administrative7.6M10.3M9.5M9.2M10.5M6.9M
Other Operating Expenses26.2M37.2M36.3M35.8M41.2M23.5M
Operating Income(18.9M)(30.3M)(29.6M)(28.6M)(25.8M)(27.0M)
Ebit(21.6M)(31.0M)(36.7M)(27.9M)(25.1M)(26.4M)
Research Development9.9M15.3M14.7M14.4M16.5M10.2M
Ebitda(19.5M)(28.6M)(34.6M)(26.8M)(24.1M)(25.3M)
Total Operating Expenses22.3M33.2M32.6M33.0M37.9M21.3M
Income Before Tax(21.6M)(30.6M)(28.4M)(28.7M)(25.8M)(27.1M)
Total Other Income Expense Net2.4M(303K)3.7M(81K)(93.2K)(88.5K)
Net Income(21.6M)(30.7M)(28.7M)(28.6M)(25.7M)(27.0M)
Income Tax Expense45K105K287K(128K)(147.2K)(139.8K)
Tax Provision45K105K287K(128K)(147.2K)(139.8K)
Interest Income692K205K803K1.6M1.9M2.0M
Total Revenue7.3M6.9M6.7M7.2M8.3M4.7M
Gross Profit3.5M3.0M3.0M4.4M5.0M2.5M
Net Income From Continuing Ops(21.6M)(30.7M)(28.7M)(28.6M)(25.7M)(27.0M)
Cost Of Revenue3.8M3.9M3.7M2.8M3.2M2.7M
Net Income Applicable To Common Shares(15.2M)(21.6M)(30.7M)(28.7M)(25.8M)(27.1M)
Net Interest Income149K(310K)919K726K834.9K876.6K
Selling And Marketing Expenses4.9M7.7M8.5M9.5M10.9M5.5M
Reconciled Depreciation1.5M1.9M1.6M1.1M1.3M1.5M

Currently Active Assets on Macroaxis

When determining whether Profound Medical Corp is a strong investment it is important to analyze Profound Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Profound Medical's future performance. For an informed investment choice regarding Profound Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Profound Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Profound Medical. If investors know Profound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Profound Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.35)
Revenue Per Share
0.38
Quarterly Revenue Growth
0.639
Return On Assets
(0.45)
Return On Equity
(0.90)
The market value of Profound Medical Corp is measured differently than its book value, which is the value of Profound that is recorded on the company's balance sheet. Investors also form their own opinion of Profound Medical's value that differs from its market value or its book value, called intrinsic value, which is Profound Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Profound Medical's market value can be influenced by many factors that don't directly affect Profound Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Profound Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Profound Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Profound Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.